Li Tai Fang

机构：Freenome (United States) · ORCID：0000-0003-3201-5162

发表论文 60 篇 · 总被引 1619 次 · h-index 19

代表论文

• Toward best practice in cancer mutation detection with whole-genome and whole-exome sequencing (2021 · Nature Biotechnology · 被引 219)
• PrecisionFDA Truth Challenge V2: Calling variants from short and long reads in difficult-to-map regions (2022 · Cell Genomics · 被引 209)
• Establishing community reference samples, data and call sets for benchmarking cancer mutation detection using whole-genome sequencing (2021 · Nature Biotechnology · 被引 153)
• precisionFDA Truth Challenge V2: Calling variants from short- and long-reads in difficult-to-map regions (2020 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 67)
• Whole genome and exome sequencing reference datasets from a multi-center and cross-platform benchmark study (2021 · Scientific Data · 被引 62)
• Concordance of Genomic Alterations by Next-Generation Sequencing in Tumor Tissue versus Cell-Free DNA in Stage I–IV Non–Small Cell Lung Cancer (2019 · Journal of Molecular Diagnostics · 被引 61)